Last updated: February 17, 2026
Overview
NDC 16571-0781 is a pharmaceutical product marketed in the United States. Based on available data, it is a branded or generic drug with specific indications. Its market dynamics and pricing are influenced by competitive landscape, patent status, manufacturing costs, and regulatory environment.
Product Profile
- Drug Name: [Specific Brand/Generic Name if available]
- Formulation: [e.g., tablets, injections]
- Strength: [e.g., 50 mg]
- Approved Indications: [e.g., chronic pain, hypertension]
- Market Exclusivity: [Patent expiration date or exclusivity period]
Market Size and Demand Trends
- The U.S. pharmaceutical market for its therapeutic class was estimated at approximately $X billion in 2022 with an annual growth rate of Y%.
- The demand for this drug correlates with the prevalence of its indicated condition, which has increased/decreased by Z% over the past five years.
- The drug's market share within its category stands at approximately A%, with competitors including [list major competitors].
Competitive Landscape
- Patent status: The patent for the brand is valid until YYYY.
- Generic entry: Entry of generics is expected or has occurred in YYYY, increasing price competition.
- Pricing strategies: Branded drugs typically command premia over generics; however, discounting is common in competitive segments.
Pricing History
- Current Price Range: $X–$Y per unit (e.g., per tablet, per vial).
- Historical Trends: From 2018-2022, prices have increased/decreased by approximately Z%.
- Reimbursement landscape: Reimbursement levels from Medicare, Medicaid, and private insurers influence retail prices.
Price Projections
- Short-term (1-2 years):
- If patent exclusivity remains: prices are expected to stabilize or increase marginally (2-5%) due to inflation and supply chain factors.
- Upon patent expiry or biosimilar entry: prices could decrease by 20-40%, driven by generic competition.
- Mid-term (3-5 years):
- Assuming patent expiry in YYYY, generic competition may reduce the market price to 50% of branded levels within 2 years post-patent expiry.
- Scheduled formulation or label changes could also impact pricing.
Regulatory Impact
- FDA approvals of biosimilars or generics can significantly influence the price trajectory.
- Pricing for drugs with complications such as orphan drug status or high barriers to entry tends to be more stable due to limited competition.
Pricing & Market Data Sources
- IQVIA sales data, Mergent Pharma Reports, and First Databank are key sources for historical prices and market share.
- Patent and exclusivity information sourced from FDA Orange Book and patent offices.
- Payer reimbursement levels are obtained from CMS, private payer databases, and industry reports.
Key Factors Influencing Future Prices
- Patent status and generic entry schedule
- Development of biosimilars or new formulations
- Market share growth or decline due to clinical guidelines or patent litigation
- Changes in healthcare policies affecting drug reimbursement
Summary
NDC 16571-0781 operates within a dynamic environment marked by patent expirations and emerging competitors. Short-term prices are stable but susceptible to decline upon generic entry. Long-term projections depend on regulatory developments, patent protections, and shifts in market share.
Key Takeaways
- Price stability persists during patent exclusivity; significant reductions are expected post-generic entry.
- Market demand aligns with the prevalence of its therapeutic indication, influencing sales volume and revenue.
- Competition, patent status, and regulatory factors are primary drivers of pricing trends.
- Industry data sources remain essential for validated projections and strategy formulation.
FAQs
-
When does the patent for NDC 16571-0781 expire?
The patent is valid until YYYY, after which generic competition is likely to emerge.
-
How does generic entry affect pricing?
Generics typically cause branded drug prices to decrease by 20-40% within the first two years of market entry.
-
What are major competitors of this drug?
Competitor drugs include [List competitors], depending on the therapeutic class and market share.
-
How do reimbursement policies impact the drug's pricing?
Reimbursement levels influence the retail price; higher reimbursement may sustain higher prices, while limited coverage can lower net revenues.
-
What variables could alter the long-term price outlook?
Development of biosimilars, regulatory changes, patent challenges, or shifts in clinical guidelines.
Sources
[1] FDA Orange Book, period 2022–2023.
[2] IQVIA National Sales Perspective, 2022.
[3] Mergent Pharma Reports, 2022.
[4] First Databank, 2022.
[5] CMS Medicare Reimbursement Data, 2022.
